Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New therapies for systemic lupus erythematosus — past imperfect, future tense
Gráinne Murphy, David Isenberg
Nature Reviews Rheumatology (2019) Vol. 15, Iss. 7, pp. 403-412
Open Access | Times Cited: 133

Showing 26-50 of 133 citing articles:

Stratification of Patients With Sjögren’s Syndrome and Patients With Systemic Lupus Erythematosus According to Two Shared Immune Cell Signatures, With Potential Therapeutic Implications
Lucia Martin‐Gutierrez, Junjie Peng, Nicolyn Thompson, et al.
Arthritis & Rheumatology (2021) Vol. 73, Iss. 9, pp. 1626-1637
Open Access | Times Cited: 37
Restoration of NK Cell Cytotoxic Function With Elotuzumab and Daratumumab Promotes Elimination of Circulating Plasma Cells in Patients With SLE
Morgane Humbel, Florence Bellanger, Natalia Fluder, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 34
Aberrant B Cell Signaling in Autoimmune Diseases
Odilia B. J. Corneth, Stefan F. H. Neys, Rudi W. Hendriks
Cells (2022) Vol. 11, Iss. 21, pp. 3391-3391
Open Access | Times Cited: 23
Natural language processing to identify lupus nephritis phenotype in electronic health records
Yu Deng, Jennifer A. Pacheco, Anika Ghosh, et al.
BMC Medical Informatics and Decision Making (2024) Vol. 22, Iss. S2
Open Access | Times Cited: 5
A highly potent lymphatic system–targeting nanoparticle cyclosporine prevents glomerulonephritis in mouse model of lupus
Raghu Ganugula, Meenakshi Arora, Dianxiong Zou, et al.
Science Advances (2020) Vol. 6, Iss. 24
Open Access | Times Cited: 37
Monoclonal Antibody-Based Therapies for Myasthenia Gravis
Sawsan Alabbad, Mohanad AlGaeed, Patricia Sikorski, et al.
BioDrugs (2020) Vol. 34, Iss. 5, pp. 557-566
Open Access | Times Cited: 33
Increased apolipoprotein-B:A1 ratio predicts cardiometabolic risk in patients with juvenile onset SLE
George Robinson, Kirsty E. Waddington, Leda Coelewij, et al.
EBioMedicine (2021) Vol. 65, pp. 103243-103243
Open Access | Times Cited: 31
EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice
Lingling Wu, Xiaoyue Jiang, Chaojun Qi, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 30
Interferon α Enhances B Cell Activation Associated With FOXM1 Induction: Potential Novel Therapeutic Strategy for Targeting the Plasmablasts of Systemic Lupus Erythematosus
Kanae Akita, Ken Yasaka, Tsuyoshi Shirai, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 27
B cell-activating factor and its targeted therapy in autoimmune diseases
Yidan Zhang, Jie Tian, Fan Xiao, et al.
Cytokine & Growth Factor Reviews (2021) Vol. 64, pp. 57-70
Closed Access | Times Cited: 27
IgG4‐Related Disease (IgG4‐RD) Autoimmune Pancreatitis (AIP) as an Initial Presentation of Systemic Lupus Erythematosus (SLE)
Srilatha Kothandaraman, Rithwik Terala
Clinical Case Reports (2025) Vol. 13, Iss. 4
Open Access
Exploring the role of gut microbiota modulation in the long-term therapeutic benefits of early MSC transplantation in MRL/lpr mice
Quanren Pan, Fengbiao Guo, Jiaxuan Chen, et al.
Cellular & Molecular Biology Letters (2025) Vol. 30, Iss. 1
Open Access
The kinase IRAK4 promotes endosomal TLR and immune complex signaling in B cells and plasmacytoid dendritic cells
Cesar A. Corzo, Eugene Varfolomeev, Audi Setiadi, et al.
Science Signaling (2020) Vol. 13, Iss. 634
Closed Access | Times Cited: 31
Systemic lupus erythematosus: year in review 2019
Yong Fan, Yanjie Hao, Zhuoli Zhang
Chinese Medical Journal (2020) Vol. 133, Iss. 18, pp. 2189-2196
Open Access | Times Cited: 31
Discovery of BIIB068: A Selective, Potent, Reversible Bruton’s Tyrosine Kinase Inhibitor as an Orally Efficacious Agent for Autoimmune Diseases
Bin Ma, Tonika Bohnert, Kevin L. Otipoby, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 21, pp. 12526-12541
Closed Access | Times Cited: 30
<p>Towards Precision Medicine in Systemic Lupus Erythematosus</p>
Elliott Lever, Marta Rebocho Alves, David Isenberg
Pharmacogenomics and Personalized Medicine (2020) Vol. Volume 13, pp. 39-49
Open Access | Times Cited: 29
Are lupus animal models useful for understanding and developing new therapies for human SLE?
Erica Moore, Chaim Putterman
Journal of Autoimmunity (2020) Vol. 112, pp. 102490-102490
Open Access | Times Cited: 28
Empirical and Rational Design of T Cell Receptor-Based Immunotherapies
Heather F. Jones, Zaki Molvi, Martin G. Klatt, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 26
Ultrasound to identify systemic lupus erythematosus patients with musculoskeletal symptoms who respond best to therapy: the US Evaluation For mUsculoskeletal Lupus longitudinal multicentre study
Khaled Mahmoud, Ahmed S Zayat, Md Yuzaiful Md Yusof, et al.
Lara D. Veeken (2021) Vol. 60, Iss. 11, pp. 5194-5204
Open Access | Times Cited: 24
The Therapeutic Strategies for SLE by Targeting Anti-dsDNA Antibodies
Yaqi Wang, Shengxiang Xiao, Yumin Xia, et al.
Clinical Reviews in Allergy & Immunology (2021) Vol. 63, Iss. 2, pp. 152-165
Open Access | Times Cited: 24
Humanized Mouse Models of Systemic Lupus Erythematosus: Opportunities and Challenges
Jiaxuan Chen, Shuzhen Liao, Huimin Zhou, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 17
The dualistic role of Lyn tyrosine kinase in immune cell signaling: implications for systemic lupus erythematosus
Elan L’Estrange-Stranieri, Timothy A. Gottschalk, Mark D. Wright, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
PROSPECTS FOR ANTI-B-CELL THERAPY IN IMMUNO-INFLAMMATORY RHEUMATIC DISEASES
Е. Л. Насонов, Т. V. Beketova, L. P. Ananyeva, et al.
Rheumatology Science and Practice (2019) Vol. 57, pp. 1-40
Open Access | Times Cited: 28
Real world treatment of juvenile-onset systemic lupus erythematosus: Data from the UK JSLE cohort study
Eve Smith, Naomi Egbivwie, Andrea Jorgensen, et al.
Clinical Immunology (2022) Vol. 239, pp. 109028-109028
Open Access | Times Cited: 14
Management of Severe Refractory Systemic Lupus Erythematosus: Real-World Experience and Literature Review
Huaxia Yang, Huazhen Liu, Ziyue Zhou, et al.
Clinical Reviews in Allergy & Immunology (2020) Vol. 60, Iss. 1, pp. 17-30
Closed Access | Times Cited: 22

Scroll to top